Med-Surge Takes Aim At Candela In Targeting Facial Acne, Sebaceous Glands

Med-Surge is positioning itself to be a direct competitor to Candela in the laser acne treatment market with a planned facial indication for its "non-ablative" Aramis Er: Glass system

More from Archive

More from Medtech Insight